Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Acute graft-versus-host disease: New treatment strategies
Sophie Paczesny
, Sung W. Choi
,
James L.M. Ferrara
Research output
:
Contribution to journal
›
Review article
›
peer-review
61
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Acute graft-versus-host disease: New treatment strategies'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Graft-versus-host Disease (GvHD)
100%
New Treatment Options
100%
Pathophysiology
33%
Regulatory T Cells
33%
Hematopoietic Cell Transplantation
33%
Monoclonal Antibody
16%
B Cells
16%
Chemotherapy
16%
Dendritic Cells
16%
Cell-to-cell
16%
Sirolimus
16%
Phase III Clinical Trial
16%
Response Rate
16%
Immune Reconstitution
16%
Therapeutic Care
16%
Tight
16%
Cell Therapy
16%
New Agents
16%
Mesenchymal Stem Cells
16%
Supportive Care
16%
Immunomodulatory
16%
Disease Response
16%
NKT Cells
16%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
16%
Innovative Strategies
16%
Extracorporeal Photopheresis
16%
Graft-versus-leukemia Effect
16%
Immunomodulatory Drugs (IMiDs)
16%
Future Therapies
16%
Anti-tumor Necrosis Factor Antibody
16%
LFA-3
16%
Life-threatening Infections
16%
Cellular Effectors
16%
IgG Fusion Protein
16%
Medicine and Dentistry
Graft Versus Host Reaction
100%
Acute Graft Versus Host Disease
100%
Cell Transplantation
60%
Hematopoietic Cell
60%
Pathophysiology
40%
Regulatory T Cell
40%
Gene Linkage
20%
Clinical Trial
20%
Monoclonal Antibody
20%
B Cell
20%
Infection
20%
Rapamycin
20%
Dendritic Cell
20%
Immune Reconstitution
20%
Mesenchymal Stem Cell
20%
Supportive Care
20%
Natural Killer T Cell
20%
Photopheresis
20%
Immunomodulatory Drug
20%
Chimeric Protein
20%
Graft Versus Leukemia Effect
20%
Lymphocyte Function Associated Antigen 3
20%
Tumor Necrosis Factor Antibody
20%
Immunology and Microbiology
Graft-Versus-Host Disease
100%
Acute Graft Versus Host Disease
100%
Hematopoietic Cell
60%
Cell Transplantation
60%
Regulatory T Cell
40%
Monoclonal Antibody
20%
B Cell
20%
Dendritic Cell
20%
Lymphocyte Function Associated Antigen 3
20%
Immune Reconstitution
20%
Experimental Model
20%
Mesenchymal Stem Cell
20%
Natural Killer T Cell
20%
Sirolimus
20%
Immunomodulatory Drug
20%
Tumor Necrosis Factor Antibody
20%
Infection
20%
Pharmacology, Toxicology and Pharmaceutical Science
Graft Versus Host Reaction
100%
Acute Graft Versus Host Disease
100%
Pathophysiology
40%
Monoclonal Antibody
20%
Clinical Trial
20%
Chemotherapy
20%
Infection
20%
Rapamycin
20%
Leukemia
20%
Lymphocyte Function Associated Antigen 3
20%
Chimeric Protein
20%
Tumor Necrosis Factor Antibody
20%